Signatera Assessment in Early-Stage Endometrial Cancer

Clinical trial NCT07339384 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07339384
Sponsor: Natera, Inc.
Status: NOT_YET_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Endometrial Cancer

Start date: 2026-10-01
Primary completion: 2034-10-01
Enrollment: 1010

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.